Fairvalue-Calculator Fairvalue-Calculator
EN DE

PCC Exol S.A (PCX) Fair Value & Analysis

Basic Materials · PL · Market cap 341M PLN

Price1.92 PLN
Fair Value2.98 PLN
Upside+55.6%
Quality95/100
Evidence: High Range 2.34 PLN – 4.63 PLN

Fair value as of: Jun 24, 2026

Analysis

PCC Exol S.A (PCX) currently trades at 1.92 PLN, while our model-based Fair Value estimate is 2.98 PLN — implying the stock looks roughly 55.6% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PCC Exol S.A. manufactures and distributes surfactants in Poland and internationally. The company offers anionic, nonionic, cationic, and amphoteric surfactants. Its products are used in household chemicals, personal care products, textile, and industrial applications, as well as used as wetting agents, emulsifiers, and auxiliary agents in the paper, metallurgy, and many other areas. The company was incorporated in 2008 and is headquartered in Brzeg Dolny, Poland. PCC Exol S.A. is a subsidiary of PCC SE.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is PCC Exol S.A (PCX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2.98 PLN versus a price of 1.92 PLN — about +56% (undervalued). Model-based estimate, not financial advice.
What is the fair value of PCX?
Our 21-model fair value for PCC Exol S.A is 2.98 PLN (as of Jun 24, 2026), built from audited fundamentals. The current price is 1.92 PLN.
What is the quality score of PCX?
PCC Exol S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.